Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Helmut Jeggle
Age : 51
Public asset : 587,058,551 USD
Country of residence : Unknown
Linked companies : BioNTech SE - tonies SE - 4SC AG

Biography of Helmut Jeggle 
Helmut Jeggle is a businessperson who has been at the helm of 23 different companies. Currently, he occupies the position of Chairman-Supervisory Board of BioNTech SE, Managing Director at AT Newtec GmbH, Co-Managing Director at Jossa Arznei GmbH, Co-Managing Director at Santo Service GmbH, Managing Director at Avitop GmbH, Co-Chief Executive Officer for Neuraxpharm Holding GmbH, Managing Director & Chief Financial Officer at Nx Biotech GmbH, Managing Director at Horus Sentilo Projektentwicklungsgesellschaft mbH, Chief Executive Officer for Salvia GmbH, Co-Managing Director at SWB Holding GmbH (Bayern), Co-Managing Director at A&T Grundstück 1 GmbH, Co-Managing Director at A&T Grundstück 2 GmbH, Co-Managing Director at Palais Berlin 1 GmbH, Chairman-Supervisory Board at AiCuris Anti-infective Cures GmbH, Co-Managing Director at Santo Holding (Deutschland) GmbH, Chief Operating Officer & Co-Managing Director at Athos Service GmbH, Co-Managing Director at Objektgesellschaft Berlin Passauer Straße 5-7 mbH, Co-Managing Director at Objektgesellschaft München Jahnstraße 41 und Klenzestraße, Managing Director at Santo Venture Capital GmbH, Chief Executive Officer & General Partner at ATHOS KG and Managing Director at ATS Beteiligungsverwaltung GmbH. He is also Co-Managing Director at AT Impf GmbH and Managing Director at Apceth Biopharma Manufacturing Co. Gmbh and on the board of 6 other companies. In the past Helmut Jeggle occupied the position of Managing Director at Klinge Pharma GmbH (Bayern), Chairman-Management Board at Sidroga AG, Managing Director at apceth Biopharma GmbH, Head-Business Planning & Analysis at H e x a l AG and Head-Business Planning & Analysis at Sandoz International GmbH. Helmut Jeggle received an undergraduate degree from Neu-Ulm University of Applied Sciences and an MBA from Stuttgart Institute of Management & Technology GmbH.


Current positions of Helmut Jeggle 
Holdings of Helmut Jeggle 
Helmut Jeggle : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Helmut Jeggle : Connections 


Latest news about Helmut Jeggle 
2021PRESS RELEASE : AiCuris AG Announces Dr. Stefan Oschmann, Former Merck CEO, to Chair the AiCuris Supervisory Board
DJ
2021PRESS RELEASE : BioNTech Broadens Management Board by Appointing Jens Holstein as CFO
DJ
2021PRESS RELEASE : Creative Balloons closes EUR15 million growth financing and appoints Frank Gehres as CEO
DJ
2021PRESS RELEASE : AiCuris changes its legal form: AiCuris Anti-infective Cures GmbH becomes AiCuris AG
DJ
2021BioNTech investor, amid worry over shortage, vows vaccines to be delivered for second shot
RE
2020BIONTECH : How a Couple's Quest to Cure Cancer Led to the West's First Covid-19 Vaccine
DJ
More news